SleepCited

5-HTP for Sleep Onset Difficulty

D Preliminary

Based on 7 studies. 7/7 studies show positive effects.

Key Statistics

7

Studies

--

Participants

↑

Positive

D Preliminary

Grade

Referenced Papers

Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. Other
Psychopharmacology 2025 5 citations
Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats. Other
International immunopharmacology 2025 1 citations
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides. Other
RSC advances 2019 13 citations
Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems. Other
Nutrition research and … 2018 12 citations
Flos Albiziae aqueous extract and its active constituent quercetin potentiate the hypnotic effect of pentobarbital via the serotonergic system. Other
Biomedical reports 2015 12 citations
Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep behaviors in mice. Other
European journal of … 2014 43 citations
Spinosin, a C-glycoside flavonoid from semen Zizhiphi Spinozae, potentiated pentobarbital-induced sleep via the serotonergic system. Other
Pharmacology, biochemistry, and … 2008 76 citations

Dosage & Usage

Commonly Used Dosages

sleep:
100-300 mg, 30-45 min before bed

Upper limit: Not established; serotonin syndrome risk with SSRIs

Dosages Studied in Research

Dosage Süre Effect N
None -- Positive --
Cinnamic acid (CA) administered to rats (dose not specified) -- Positive --
up to 96 mg/kg -- Positive --
not fully specified (dose ranges tested in Drosophila, ICR mice, and SD rats) -- Positive --
various doses; pentobarbital 50 mg/kg (full dose) or 28 mg/kg (sub-hypnotic dose) IP -- Positive --
5-45 mg/kg i.p. schizandrin -- Positive --
Spinosin various doses; pentobarbital 45 mg/kg or 28 mg/kg i.p.; 5-HTP 2.5 mg/kg i.p.; PCPA 300 mg/k -- Positive --

Best taken: 30-45 minutes before bed

Safety & Side Effects

Reported Side Effects

  • ⚠ Nausea
  • ⚠ Diarrhea
  • ⚠ Heartburn
  • ⚠ Stomach pain
  • ⚠ Drowsiness

Known Interactions

  • ● SSRIs/SNRIs — serious risk of serotonin syndrome
  • ● MAOIs — dangerous serotonin accumulation
  • ● Tramadol — increased serotonin syndrome risk
  • ● Carbidopa — may cause scleroderma-like skin changes

Tolerable upper intake: Not established; serotonin syndrome risk with SSRIs

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does 5-HTP help with Sleep Onset Difficulty?
Based on 7 studies with 0 participants, there is preliminary evidence that needs more research that 5-HTP may support Sleep Onset Difficulty management. Our evidence grade is D (Preliminary).
How much 5-HTP should I take for Sleep Onset Difficulty?
Studies have used various dosages. A commonly studied range is 100-300 mg, 30-45 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Diarrhea, Heartburn, Stomach pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and Sleep Onset Difficulty?
We rate the evidence as Grade D (Preliminary). This rating is based on 7 peer-reviewed studies with 0 total participants. The overall direction of effect is positive.

Related Evidence

5-HTP for other conditions

Insomnia B Moderate

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.